EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Glycosylation control strategies for recombinant therapeutic proteins in CHO cells

Weifeng Wang, Weidong Li, Qianwen Wang, Xuekun Li, Tianyun Wang, Junhe Zhang

Biochimie · 2026-06 · 245 · 72-87

DOI: 10.1016/j.biochi.2026.02.020 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biochimie, 2026-06. Verfasst von Weifeng Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institutes of Health Central Plains, Xinxiang Key Laboratory for Tumor Drug Screening and Targeted Therapy, Xinxiang Medical University, Xinxiang, 45…. Hauptthemen laut MEDLINE: Recombinant Proteins, Protein Processing, Post-Translational. Die Arbeit nennt 140 Literaturangaben. Gefördert von: Foundation for Innovative Research Groups of the National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chinese hamster ovary (CHO) cells are widely employed as host cells for the production of recombinant therapeutic proteins (RTPs). Glycosylation, a crucial post-translational modification, significantly affects the function and quality of RTPs expressed in CHO cells. This modification not only influences protein folding, stability, and immunogenicity, but also dictates their biological activity and half-life. This review summarizes the biological role of glycosylation within CHO cells, analyzes both intrinsic and extrinsic factors affecting recombinant protein glycosylation, and explores recent strategies for controlling this process, such as gene editing and cell culture optimization. These approaches offer promising avenues for effectively modulating the glycosylation patterns of RTPs, thereby enhancing their biological activity and stability. Furthermore, we also discuss current challenges in controlling glycosylation and provide insights into future research directions in this field.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Recombinant ProteinsProtein Processing, Post-TranslationalAnimalsGlycosylationCHO CellsCricetulusHumansCricetinae

Stichwörter der Autor:innen

BiopharmaceuticalChinese hamster ovary cellsGenetic engineeringGlycosylationRecombinant protein

Substanzen

Recombinant Proteins

Autor:innen und Institutionen

  • Institutes of Health Central Plains, Xinxiang Key Laboratory for Tumor Drug Screening and Targeted Therapy, Xinxiang Medical University, Xinxiang, 453003, China; International Joint Research Laboratory for Recombinant P…
  • International Joint Research Laboratory for Recombinant Pharmaceutical Protein Expression System of Henan, Xinxiang, 453003, China; Henan Key Laboratory of Neurorestoratology and Protein Modification, the First Affiliat…
  • First Clinical College, Hubei University of Medicine, Shiyan, 442000, China.
  • The First Affiliated Hospital of Xinxiang Medical University, Weihui, 453100, China.

Förderung

  • Foundation for Innovative Research Groups of the National Natural Science Foundation of China

Zitieren

APA

Wang, W., Li, W., Wang, Q., Li, X., Wang, T., & Zhang, J. (2026). Glycosylation control strategies for recombinant therapeutic proteins in CHO cells. Biochimie, 245, 72-87. https://doi.org/10.1016/j.biochi.2026.02.020

Vancouver

Wang W, Li W, Wang Q, Li X, Wang T, Zhang J. Glycosylation control strategies for recombinant therapeutic proteins in CHO cells. Biochimie. 2026;245:72-87. doi:10.1016/j.biochi.2026.02.020

BibTeX
@article{Wang2026,
  author = {Wang, Weifeng and Li, Weidong and Wang, Qianwen and Li, Xuekun and Wang, Tianyun and Zhang, Junhe},
  title = {Glycosylation control strategies for recombinant therapeutic proteins in CHO cells},
  journal = {Biochimie},
  year = {2026},
  volume = {245},
  pages = {72--87},
  doi = {10.1016/j.biochi.2026.02.020}
}
Kostenlos starten →